Inventor · disambiguated record
David William Will
Also filed as: WILL DAVID · WILL DAVID W · WILL DAVID WILLIAM
40 granted patents·11 pending applications·542 citations·filing 1996–2018
97Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND18AVENTIS PHARMA GMBH12EUROPEAN MOLECULAR BIOLOGY LABORATORY4AVENTIS PHARMA SA3STROBEL HARTMUT3
Top patents by PatentIndex Score
51 records- 0199US7910606B2Pyrazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Mar 22, 2011·81 cites·14 claims
- 0298US7067665B2Oxybenzamide derivatives useful for inhibiting factor Xa or VllaSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Jun 27, 2006·75 cites·16 claims
- 0395US6953857B2Oxybenzamide derivatives useful for inhibiting factor Xa or viiaAVENTIS PHARMA GMBH·Filed 2001·Granted Oct 11, 2005·69 cites·14 claims
- 0493US8304438B2Heteroarylacrylamides and their use as pharmaceuticalsSTROBEL HARTMUT·Filed 2009·Granted Nov 6, 2012·30 cites·11 claims
- 0592US8299102B2Heteroarylcyclopropanecarboxamides and their use as pharmaceuticalsSTROBEL HARTMUT·Filed 2009·Granted Oct 30, 2012·27 cites·13 claims
- 0692US6313119B1Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesionAVENTIS PHARMA GMBH·Filed 2000·Granted Nov 6, 2001·32 cites·22 claims
- 0791US6340679B1Guanidine derivatives as inhibitors of cell adhesionAVENTIS PHARMA GMBH·Filed 2000·Granted Jan 22, 2002·48 cites·10 claims
- 0888US7317027B2Azaindole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jan 8, 2008·26 cites·10 claims
- 0987US6906084B2Indole derivatives as factor Xa inhibitorsAVENTIS PHARMA GMBH·Filed 2002·Granted Jun 14, 2005·30 cites·8 claims
- 1087US6660728B2Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonistsAVENTIS PHARMA GMBH·Filed 2002·Granted Dec 9, 2003·30 cites·8 claims
- 1183US7727989B24-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Jun 1, 2010·7 cites·11 claims
- 1280US5817811AProcess for preparing substituted N-ethyglycine derivativesHOECHST AG·Filed 1996·Granted Oct 6, 1998·36 cites·15 claims
- 1379US7897346B2Polyamide nucleic acid derivatives and agents, and processes for preparing themSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Mar 1, 2011·2 cites·4 claims
- 1479US6905820B2Polyamide nucleic acid derivatives, and agents and processes for preparing themAVENTIS PHARMA GMBH·Filed 2001·Granted Jun 14, 2005·7 cites·69 claims
- 1577US8188291B2Heteroaryl-substituted carboxamides and their use as pharmaceuticalsSTROBEL HARTMUT·Filed 2009·Granted May 29, 2012·3 cites·11 claims
- 1677US7470689B24-benzimidazol-2-ylpyridazin-3-one derivativesAVENTIS PHARMA SA·Filed 2006·Granted Dec 30, 2008·2 cites·12 claims
- 1776US8268560B2Polymide nucleic acid derivatives, and agents and processes for preparing themUHLMANN EUGEN·Filed 2011·Granted Sep 18, 2012·2 cites·9 claims
- 1872US6777544B2Polyamide nucleic acid derivatives and agents and processes for preparing themAVENTIS PHARMA GMBH·Filed 2001·Granted Aug 17, 2004·5 cites·78 claims
- 1971US7968546B2Pyridazinone kinase inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Jun 28, 2011·1 cites·10 claims
- 2071US7709466B2Pyridazinone derivatives, methods for their production and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted May 4, 2010·1 cites·9 claims
- 2171US6747148B2Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesionHOECHST MARION ROUSSEL DE GMBH·Filed 2001·Granted Jun 8, 2004·4 cites·6 claims
- 2270US7507734B2Pyridazinone derivativesAVENTIS PHARMA SA·Filed 2006·Granted Mar 24, 2009·1 cites·8 claims
- 2369US7488818B2Method for producing 1,4-diphenyl azetidinone derivativesSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Feb 10, 2009·1 cites·15 claims
- 2467US2008306056A1PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORSSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 2564US7550582B2Polyamide nucleic acid derivatives and agents, and processes for preparing themSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Jun 23, 2009·0 cites·8 claims
- 2663US7754713B24-benzimidazol-2-ylpyridazin-3-one derivativesAVENTIS PHARMA SA·Filed 2008·Granted Jul 13, 2010·0 cites·5 claims
- 2763US7309701B2Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing themSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Dec 18, 2007·3 cites·4 claims
- 2862US7358268B2Imidazole derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Apr 15, 2008·2 cites·5 claims
- 2961US7435747B2Guanidine and amidine derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Oct 14, 2008·1 cites·5 claims
- 3061US2008280946A1Azaindole-Derivatives As Factor Xa InhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 3160US2009069565A1New indole derivatives as factor xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 3259US2005009073A1Polyamide nucleic acid derivatives, and agents, and processes for preparing themAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 3358US6723706B2Modified antisense nucleotides complementary to a section of the human Ha-ras geneAVENTIS PHARMA GMBH·Filed 1998·Granted Apr 20, 2004·12 cites·30 claims
- 3457US2005020523A1Modified antisense nucleotides complementary to a section of the human haras geneAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
- 3555US7462613B2Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing themSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Dec 9, 2008·1 cites·14 claims
- 3655US2005043302A1New indole derivatives as factor Xa inhibitorsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 3754US8044050B2Imidazo[1,2-a]azines and their use as pharmaceuticalsSANOFI AVENTIS·Filed 2009·Granted Oct 25, 2011·0 cites·15 claims
- 3854US7241882B2Polyamide nucleic acid derivatives, and agents, and processes for preparing themSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jul 10, 2007·0 cites·7 claims
- 3953US8399476B2Imidazo[1,2-a]pyridines and their use as pharmaceuticalsZOLLER GERHARD·Filed 2009·Granted Mar 19, 2013·0 cites·7 claims
- 4053US8080569B2Imidazo[2,1-b]thiazoles and their use as pharmaceuticalsZOLLER GERHARD·Filed 2009·Granted Dec 20, 2011·0 cites·12 claims
- 4153US7429581B2Pyrazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Sep 30, 2008·0 cites·18 claims
- 4252US8168665B2Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticalsZOLLER GERHARD·Filed 2009·Granted May 1, 2012·0 cites·7 claims
- 4345US2002173656A1Guanidine and amidine derivatives as factor Xa inhibitorsFiled 2001·Application pending·0 cites
- 4445US2020223837A1Benzofuran amides and heteroaromatic analogues thereof for use in therapyEUROPEAN MOLECULAR BIOLOGY LABORATORY·Filed 2018·Application pending·0 cites
- 4540US8642620B2Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticalsSTROBEL HARMUT·Filed 2007·Granted Feb 4, 2014·0 cites·12 claims
- 4640US6566366B1Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonistsAVENTIS PHARMA GMBH·Filed 1999·Granted May 20, 2003·3 cites·10 claims
- 4740US2021147405A1Bicyclic heteroaromatic urea or carbamate compounds for use in therapyEUROPEAN MOLECULAR BIOLOGY LABORATORY·Filed 2018·Application pending·0 cites
- 4840US2020216434A1Benzofuran ureas or carbamates and heteroaromatic analogues thereof for use in therapyEUROPEAN MOLECULAR BIOLOGY LABORATORY·Filed 2018·Application pending·0 cites
- 4940US2020216435A1Bicyclic heteroaromatic amide compounds for use in therapyEUROPEAN MOLECULAR BIOLOGY LABORATORY·Filed 2018·Application pending·0 cites
- 5039US8518976B2Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticalsSTROBEL HARMUT·Filed 2007·Granted Aug 27, 2013·0 cites·9 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →